RadNet, Inc. (RDNT) stock
RDNTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3056% above fair value
$76.42+0.38 (+0.50%)
Close on Nov 13, 2026Market cap $6.01BP/E –Yield –
RadNet total assets
Total assets on the balance sheet at the end of each period.
RadNet's total assets was $4.28B at Sep 30, 2026. For fiscal 2025 it was $3.76B, up 14.4% from the year before. Over ten years it grew 59.4% a year on average. The highest annual figure on record is $3.76B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.76B | +14.4% |
| FY2024 | Dec 31, 2024 | $3.29B | +22.2% |
| FY2023 | Dec 31, 2023 | $2.69B | +10.5% |
| FY2022 | Dec 31, 2022 | $2.43B | +18.2% |
| FY2021 | Dec 31, 2021 | $2.06B | +15.2% |
| FY2020 | Dec 31, 2020 | $1.79B | +8.5% |
| FY2019 | Dec 31, 2019 | $1.65B | +48.5% |
| FY2018 | Dec 31, 2018 | $1.11B | +27.7% |
| FY2017 | Dec 31, 2017 | $868.98M | +2.3% |
| FY2016 | Dec 31, 2016 | $849.48M | +2293.3% |
| FY2015 | Dec 31, 2015 | $35.49M | -4.9% |
| FY2014 | Dec 31, 2014 | $37.32M | -8.2% |
| FY2013 | Dec 31, 2013 | $40.65M | -3.4% |
| FY2012 | Dec 31, 2012 | $42.10M | -4.1% |
| FY2011 | Dec 31, 2011 | $43.90M | -91.9% |
| FY2010 | Dec 31, 2010 | $539.51M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $4.28B | +16.8% |
| Q2 FY2026 | Jun 30, 2026 | $4.23B | +20.2% |
| Q1 FY2026 | Mar 31, 2026 | $3.89B | +16.5% |
| Q4 FY2025 | Dec 31, 2025 | $3.76B | +14.4% |
| Q3 FY2025 | Sep 30, 2025 | $3.67B | +11.9% |
| Q2 FY2025 | Jun 30, 2025 | $3.51B | +8.8% |
| Q1 FY2025 | Mar 31, 2025 | $3.34B | +12.3% |
| Q4 FY2024 | Dec 31, 2024 | $3.29B | +22.2% |
| Q3 FY2024 | Sep 30, 2024 | $3.28B | +21.8% |
| Q2 FY2024 | Jun 30, 2024 | $3.23B | +19.4% |
| Q1 FY2024 | Mar 31, 2024 | $2.97B | +23.0% |
| Q4 FY2023 | Dec 31, 2023 | $2.69B | +10.5% |
| Q3 FY2023 | Sep 30, 2023 | $2.69B | +19.6% |
| Q2 FY2023 | Jun 30, 2023 | $2.71B | +20.7% |
| Q1 FY2023 | Mar 31, 2023 | $2.41B | +12.7% |
| Q4 FY2022 | Dec 31, 2022 | $2.43B | +18.2% |
| Q3 FY2022 | Sep 30, 2022 | $2.25B | +10.0% |
| Q2 FY2022 | Jun 30, 2022 | $2.24B | +10.3% |
| Q1 FY2022 | Mar 31, 2022 | $2.14B | +17.1% |
| Q4 FY2021 | Dec 31, 2021 | $2.06B | +15.2% |
| Q3 FY2021 | Sep 30, 2021 | $2.04B | +18.9% |
| Q2 FY2021 | Jun 30, 2021 | $2.03B | +18.4% |
| Q1 FY2021 | Mar 31, 2021 | $1.83B | +7.6% |
| Q4 FY2020 | Dec 31, 2020 | $1.79B | +8.5% |
| Q3 FY2020 | Sep 30, 2020 | $1.72B | +6.2% |
| Q2 FY2020 | Jun 30, 2020 | $1.72B | +7.5% |
| Q1 FY2020 | Mar 31, 2020 | $1.70B | +11.4% |
| Q4 FY2019 | Dec 31, 2019 | $1.65B | +48.5% |
| Q3 FY2019 | Sep 30, 2019 | $1.62B | +77.7% |
| Q2 FY2019 | Jun 30, 2019 | $1.60B | +74.9% |
| Q1 FY2019 | Mar 31, 2019 | $1.53B | +65.2% |
| Q4 FY2018 | Dec 31, 2018 | $1.11B | +27.7% |
| Q3 FY2018 | Sep 30, 2018 | $910.64M | +7.4% |
| Q2 FY2018 | Jun 30, 2018 | $912.98M | +7.2% |
| Q1 FY2018 | Mar 31, 2018 | $923.63M | +8.2% |
| Q4 FY2017 | Dec 31, 2017 | $868.98M | +2.3% |
| Q3 FY2017 | Sep 30, 2017 | $847.92M | – |
| Q2 FY2017 | Jun 30, 2017 | $851.82M | – |
| Q1 FY2017 | Mar 31, 2017 | $853.98M | – |
| Q4 FY2016 | Dec 31, 2016 | $849.48M | – |
See a number that looks wrong?